Across TCGA patient cohorts, OR6C76 mutation is significantly associated with the RNA expression of many other genes, with 1,318 significant associations in total. SKCM shows the largest number of these associations.

The most reproducible OR6C76-associated genes across cancer lineages are MIR1911, PI4K2A, and SEC13. Each is linked with OR6C76 in more than 2 cancer types. Because this analysis shows association rather than direction, both OR6C76-to-partner and partner-to-OR6C76 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (OR6C76→partner) and Y-score (partner→OR6C76) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
BLCA	MIR1911 →	+0.472	+7.640	<.001	.009	3	3
SKCM	PI4K2A →	+0.477	+2.228	.001	.006	3	2
UCEC	SEC13 →	+0.464	+2.807	.001	.003	3	2
UCEC	CCNB2 →	+0.928	+3.906	<.001	<.001	3	2
UCEC	MED27 →	+0.479	+3.544	.001	.002	3	2
UCEC	STOML2 →	+0.488	+3.906	.006	<.001	3	2

Each partner links to its Q-omics profile. Showing the 6 strongest of 1,318 associations by consensus.

Exploration

OR6C76 survival (RNA) · tumor vs normal (RNA) · all OR6C76 data types